Best Life Sciences Companies in Stockholm, Sweden
The 144 best Life Sciences companies in Stockholm, Sweden in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: OxThera.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Stockholm
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | OxThera Provider of microbial-based drug products to treat hyperoxaluria | $93M | 81 mo ago | 21 | — | — | — | — |
| 2 | ITBMed Developer of monoclonal antibodies to prevent transplant rejections | $87M | 54 mo ago | 28 | David Sachs Co-Founder | WordPressApple iCloud MailMicrosoft 365+20 | — | — |
| 3 | InDex Pharmaceuticals DNA-based immunomodulatory sequence medication for the treatment of inflammtatory bowel disease. | $45M | 81 mo ago | 7 | — | — | 252 patents Nucleic‑acid‑based gastrointestinal therapeutics, especially ulcerative colitis enema formulations. | — |
| 4 | Calliditas Therapeutics Provider of small molecule based drug for inflammatory kidney disease | $45M | 83 mo ago | 40 | Renee Aguiar-Lucander CEO | WordPressMySQLPHP+15 | 28 patents Steroid-based pharmaceutical formulations, notably budesonide therapies for IgA nephropathy. | — |
| 5 | Tribune Therapeutics Developer of therapeutics for fibrotic diseases | $41M | 14 mo ago | 9 | Havard Attramadal Co-Founder | WordPressMySQLPHP+17 | 5 patents Therapeutic agents targeting CCN protein signaling pathways for disease treatment | — |
| 6 | Wilson Therapeutics De-coppering agent for the treatment of Wilson disease. | $40M | 102 mo ago | 16 | — | — | 9 patents Copper‑chelating thiomolybdate compounds for Wilson disease therapy and formulation | — |
| 7 | EnginZyme Developer of immobilized enzymes | $35M | 42 mo ago | 59 | Samuel Hargestam Co-Founder | — | 48 patents Patents concentrated in chemistry & materials | 1 partnership |
| 8 | Elypta Provider of liquid biopsy-based molecular diagnostics for cancer detection | $28M | 48 mo ago | 27 | Karl Bergman CEO | WebflowAmazon Web ServicesPlausible+10 | 25 patents Diagnostic biomarkers for cancer and arthritic disease detection and discrimination | 1 partnership |
| 9 | Modus Therapeutics Developers of polysaccharide based drug for the treatment of Sickle Cell Disease | $23M | 59 mo ago | 2 | Ellen Donnelly CEO | — | 40 patents Heparin‑derived therapeutic repurposing for endotoxemia and chronic kidney disease treatment | — |
| 10 | SciBase Provider of POC device for the detection of malignant melanoma | $22M | 60 mo ago | 22 | Stig Ollmar Founder | WordPressMySQLPHP+22 | 62 patents Electrical impedance measurement devices for tissue diagnostics and epithelial barrier analysis | — |
| 11 | Sigrid Therapeutics Developer of therapies to treat metabolic and chronic lifestyle diseases | $18M | 5 mo ago | 17 | Sana Alajmovic Co-Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+16 | 50 patents Porous silica particles for oral drug delivery, supplements, and dental care formulations. | 1 launch |
| 12 | One-carbon Therapeutics Developer of therapeutics to treat cancers, inflammation, and autoimmune diseases | $16M | 6 mo ago | 3 | — | — | — | — |
| 13 | Devyser Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | $15M | 64 mo ago | 106 | — | DrupalApple iCloud MailMicrosoft 365+27 | — | — |
| 14 | Diamyd Medical Developer of therapies for the treatment and prevention of autoimmune diabetes | $13M | 90 mo ago | 46 | Ulf Hannelius President & CEO | Cart FunctionalityPleskYouTube+12 | 113 patents Personalized antigen-specific immunotherapy for type 1 diabetes based on patient genotype | 4 expansions |
| 15 | RSPR Pharma Specialty company focused on developing treatment for respiratory diseases | $12M | 141 mo ago | — | Carl-Johan Dalsgaard CEO & Founder | — | 28 patents Crystalline pharmaceutical forms of pemirolast for asthma treatment | — |
| 16 | Episurf Patient specific joint resurfacing treatment | $12M | 66 mo ago | 35 | — | WordPressMySQLPHP+8 | — | 2 launchs |
| 17 | IRRAS Provider of devices for fluid control and management after surgery | $11M | 121 mo ago | 52 | Will Martin CEO | WordPress Block EditorWordPressMySQL+20 | 33 patents Medical fluid exchange catheters for intravascular therapy and sensing | — |
| 18 | Bioservo Developer of assistive devices enhancing grip strength and fine motor skills | $9M | 74 mo ago | 20 | — | Craft CMSPHPYii+13 | 15 patents Hand‑grip strengthening wearable gloves for rehabilitation and performance enhancement | — |
| 19 | Single Technologies Developer of a technology platform for single-molecule imaging | $8M | 27 mo ago | 24 | — | — | — | — |
| 20 | Symcel Microcalorimeter for cell metabolism measurements | $6M | 102 mo ago | 32 | Jesper Ericsson CEO | HubSpot CMS HubHubSpotFancyBox+16 | 12 patents Rapid calorimetric antimicrobial susceptibility testing for clinical microbiology | 2 launchs |
| 21 | Pixelgen Technolgies Developer of ground-breaking technologies for biomedical research and diagnostics | $6M | 32 mo ago | 23 | Filip Karlsson Co-Founder | WordPressMySQLPHP+16 | — | — |
| 22 | Alba Health Provider of personalized nutrition plans and coaching services for children | $5M | 12 mo ago | — | Willem De Vos Co-Founder | Cart FunctionalityShopifyVisa+17 | — | — |
| 23 | Observe Medical A single use, digital urine meter which measures biofilm build-up | $5M | 9 mo ago | 17 | — | WordPressMySQLPHP+16 | — | 1 job opening |
| 24 | Antrad Thawed, ready to use blood plasma | $4M | 130 mo ago | 5 | — | — | — | — |
| 25 | Athera Biotechnologies Developing MAb and a companion diagnostic kit for cardiovascular diseases | $3M | 126 mo ago | 4 | — | — | 140 patents Patents concentrated in chemistry & materials | — |
| 26 | Oxcia Developing therapies targeting DNA Damage Response to cure cancer and inflammation | $3M | 39 mo ago | — | Ulrika Berglund CEO | — | — | 2 partnerships |
| 27 | Abera Bioscience Early stage vaccine development company using a platform based on Gram-negative bacteria and derived Outer… | $2M | 55 mo ago | 6 | Maria Alriksson CEO | WordPressMySQLPHP+13 | 31 patents Engineered bacterial outer membrane vesicle display and cell‑free protein production for vaccine antigens | 1 award |
| 28 | Epigenica Provider of solutions for the analysis of genomic data | $2M | 11 mo ago | — | Simon Alsatian Co-Founder | — | 14 patents Multiplexed cfDNA sequencing and chromatin modification profiling for epigenetic analysis | — |
| 29 | Interlinked Provider of safety connector device for IV infusion therapy | $2M | 69 mo ago | — | Rebecca Bejhed Co-Founder | Wix eCommerceWixSentry+13 | 9 patents Medical fluid coupling systems with coated, lubricated interfaces for secure tube connections | — |
| 30 | Scint-X Scintillator products for X-Ray Imaging | $2M | 153 mo ago | 5 | — | — | 46 patents Microfabricated scintillator structures for high‑resolution X‑ray imaging detectors | — |
| 31 | BrainZell Developer of lab-grown cell based models of the human brain for drug development | $1M | 21 mo ago | 2 | Robin Pronk Co-Founder | — | — | — |
| 32 | Inossia Developer of softener for the treatment of osteoporotic bone | $1M | 36 mo ago | 8 | Malin Nilsson Founder & CEO | — | 8 patents Acrylic bone cement formulations for orthopedic bone augmentation procedures. | — |
| 33 | Med Universe Patient case software for life science industry | $1M | 76 mo ago | 14 | Anna Norin Co-Founder & CEO | SentryTypeScriptSalesforce+11 | — | — |
| 34 | BioReperia Develops animal model for oncology and toxicology | $882K | 65 mo ago | 24 | — | — | — | — |
| 35 | AAX Biotech Developer of immunotherapies for cancer and autoimmune therapies | $685K | 4 mo ago | — | Maria Knudsen CEO | Cart FunctionalitySquarespace CommerceSquarespace+14 | 2 patents Therapeutic agent and target binding site discovery and design in biotechnology | — |
| 36 | NEOGAP Developer of radiopharmaceuticals for the treatment of cancer | $473K | 4 mo ago | 21 | Samuel Svensson CEO | WordPressMySQLPHP+28 | — | — |
| 37 | UTI-lizer Provider of urinary tract infection diagnostic test solution | $285K | 36 mo ago | 5 | Wouter Wijngaart Co-Founder | — | — | — |
| 38 | Magnea Cloud-based analytics software and AI based wearable sensor system to monitor and track patient activity | $231K | 123 mo ago | 4 | Johan Hedeva Co-Founder & CEO | — | — | — |
| 39 | NOSA plugs Nasal plug to reduce odors and widen nasal passages | $168K | 120 mo ago | — | Adrian Liljefors CEO | Cart FunctionalityWooCommerceWordPress+36 | — | — |
Top 12 Life Sciences companies in Stockholm
#1
Series C · Stockholm, Stockholm County · founded 2014 · 17 employees$17.5Mraised▾
Developer of therapies to treat metabolic and chronic lifestyle diseases. The company has developed a material platform technology, SiPore an orally administered silica-based powder product. It has multiple applications including gestational and pediatric type 2 diabetes and obesity, modulation of the gut microbiome, treatment of excessive bile acid levels post-bariatric surgery, NASH, weight loss, and infantile colic.
- Jan 2026Series C$5M
- Oct 2023Series B$4M
- Jan 2023Series A$1M
- Nov 2021Series A$8.4M
#2
Series B · Stockholm, Stockholm County · founded 2019 · 3 employees$16.2Mraised▾
Developer of therapeutics to treat cancers, inflammation, and autoimmune diseases. It offers one-carbon metabolism pathway-based therapeutics that target DNA repair and DNA damage response for the treatment of BRCA mutated cancer with PARP inhibitors.
- Dec 2025Series B$16.2M
#3
Series A · Stockholm, Stockholm County · founded 2020 · 9 employees$40.8Mraised▾
Developer of therapeutics for fibrotic diseases. The medicines target the CCN protein family which is a group of signaling proteins central to the development of fibrosis; the process of exaggerated scar tissue formation.
- Mar 2025Series A$24.8M
- 2020Seed$16M
#4
Public · Stockholm, Stockholm County · founded 2008 · 17 employees$4.6Mraised▾
Observe Medical has developed, Sippi, a single use, digital urine meter which measures biofilm build-up via non-contact capacitive sensors, delivering constant throughput, and incorporating hourly diuresis, data storage and automatic emptying.
- Sep 2025Post IPO$1M
- Jun 2025Post IPO$3.6M
- 2013Seed—
- 2010Seed—
#5
Seed · Stockholm, Stockholm County · founded 2020$684.9Kraised▾
Developer of immunotherapies for cancer and autoimmune therapies. It offers Seqitope an antibody epitope mapping method, Opti-mAb for CAR-T cells, and bispecific antibodies development for cancer treatment.
- Feb 2026Seed—
- Oct 2024Seed$684.9K
#6
Series A · Stockholm, Stockholm County · founded 2016 · 21 employees$473Kraised▾
Developer of radiopharmaceuticals for the treatment of cancer. The company has pTTL cell therapy product, which targets neoantigens by using proprietary PIOR and patented EpiTCer technologies, targeting neoantigens using immune cells from cancer patients as starting material.
- Feb 2026Series A$9.8M
- Mar 2024Seed$473K
- Nov 2023Grant (prize money)$2.6M
- 2023Grant (prize money)$8.9M
#7
Seed · Stockholm, Stockholm County · founded 2022$5Mraised▾
Provider of personalized nutrition plans and coaching services for children. It utilizes microbiome science and AI to provide personalized nutrition plans and coaching for families based on gut microbiome test for children to support healthy development and well-being from a young age.
- May 2025Seed$2.5M
- Jun 2023Seed$2M
- Grant (prize money)$500K
#8
Seed · Stockholm, Stockholm County · founded 2020$2.3Mraised▾
Provider of solutions for the analysis of genomic data. The platform is offering tools, EpiQure, for testing epigenetic drug efficacy and toxicity screening in real-life pilots, EpiFinder, for large-scale biomarker discovery for disease diagnosis and prognosis, and EpIVD, which helps in lowering the cost of epigenetic diagnostics.
- Jun 2025Seed$2.2M
- Jul 2022Grant (prize money)$125K
#9
Series B · Stockholm, Stockholm County · founded 2014 · 59 employees$34.7Mraised▾
Developer of immobilized enzymes. It employs a patented enzyme immobilization technology that enables the use of enzymes as catalysts in chemical processes. Its core technology allows for productive enzyme usage in various applications, including food, cosmetics, and pharmaceuticals.
- Dec 2022Series B$22.2M
- Feb 2021Series A$5.6M
- Apr 2020Series A$6.9M
- Jan 2020Grant (prize money)$332.2K
#10
Series A · Stockholm, Stockholm County · founded 2016 · 28 employees$87Mraised▾
Developer of monoclonal antibodies to prevent transplant rejections. The company is developing a humanized IgG1K antibody, Siplizumab which targets human CD2 molecules. The antibody binds to the human CD2 receptor found on T lymphocytes (T cells), natural killer cells, and thymocytes to inhibit their activation. The lead candidate Siplizumab is in the pivotal stage of the clinical trial for solid organ transplantation, and bone marrow transplantation.
- Dec 2021Series A$20M
- Apr 2018Angel$67M
#11
Seed · Stockholm, Stockholm County · founded 2020 · 2 employees$1.5Mraised▾
Developer of lab-grown cell-based models of the human brain intended to make medicine discovery more effective and minimize the use of animals. The company uses stem cell-based models that match the human brain better than that of animals, enabling patients to have safer pharmaceuticals.
- Aug 2024Seed$1.5M
#12
Series A · Stockholm, Stockholm County · founded 2012 · 24 employees$7.6Mraised▾
Single Technologies has developed a platform for single-molecule imaging. The company's product includes the Model Theta, a single molecule sensitive confocal microscope that provides 3D video solution based on the photon-counting detector used for single-molecule imaging.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Sweden
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 299 Sweden-affiliated papers.
- Swedish University of Agricultural Sciences53
- Karolinska Institutet52
- Uppsala University33
- Science for Life Laboratory29
- University of Gothenburg28
- Messenger RNA1→7
- Transcription (linguistics)1→4
- Gene4→5
- Gene1→5
- Antibody1→5
- Antibiotic resistance3
- Antibiotics3
- Agriculture3
- Production (economics)3
- Antimicrobial2
Where biotechnology is researched across Sweden
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.